iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mankind Pharma IPO opens for subscription on April 21

17 Apr 2023 , 09:32 AM

PE firm ChrysCapital-backed Mankind Pharma which intends to raise Rs 4500-4700 crore from the initial public offering (IPO) is opening for subscription on April 21.

The issue will close on April 25 and list on the NSE and BSE on May 4. 

As per DRHP, the issue comprises only offer for sale component where Ramesh Juneja, Rajeev Juneja and sheetal Arora are the promoters offloading their shares. While Cairnhill CIPEF Limited, Cairnhill CGPE Limited, Beige Limited, and Link Investment Trust are the investors selling their shareholding. A total of 40,058,844 equity shares will be available for subscription.

Hence, the company will not receive any proceeds from the IPO.

Mankind Pharma has not yet disclosed the issue price of the IPO.

Kotak Mahindra Capital, Axis Capital, IIFL Capital Services, Jefferies India, and J.P. Morgan India are the merchant bankers of the IPO. KFin Technologies Limited is the registrar of the issue.

Mankind Pharma IPO important details

Open date  April 21
Close date  April 25
Lot size NA
IPO size (Rs crore) NA
IPO price range (Rs) NA
Minimum investment NA
Basis of allotment date April 28
Refunds date  May 2
Credit to demat account date  May 3
Listing date  May 4
Mankind Pharma IPO

Related Tags

  • Mankind Pharma IPO
  • Mankind Pharma IPO closing date
  • Mankind Pharma IPO issue price
  • Mankind Pharma IPO issue size
  • Mankind Pharma IPO opening date
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.